United States Oncology Biosimilars Market Research Report Forecast 2017-2021
The United States Oncology Biosimilars Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Oncology Biosimilars industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Oncology Biosimilars market study provides comprehensive data which enhances the understanding, scope and application of this report.
This report provides comprehensive analysis of
Key market segments and sub-segments
Evolving market trends and dynamics
Changing supply and demand scenarios
Quantifying market opportunities through market sizing and market forecasting
Tracking current trends/opportunities/challenges
Competitive insights
Opportunity mapping in terms of technological breakthroughs
The Major players reported in the market include:
Covidien llc (Medtronic)
Johnson & Johnson MEDICAL
Bolton Surgical
Platts & Nisbett
Frankenman International
Changzhou Waston
Jiangsu Qianjing Medical
Changzhou Anker Medical
Changzhou Tongchuang Medical
United States Oncology Biosimilars Market: Product Segment Analysis
Type 1
Type 2
Type 3
United States Oncology Biosimilars Market: Application Segment Analysis
Application 1
Application 2
Application 3
Reasons for Buying this Report
This report provides comprehensive analysis of
Key market segments and sub-segments
Evolving market trends and dynamics
Changing supply and demand scenarios
Quantifying market opportunities through market sizing and market forecasting
Tracking current trends/opportunities/challenges
Competitive insights
Opportunity mapping in terms of technological breakthroughs
The Major players reported in the market include:
Covidien llc (Medtronic)
Johnson & Johnson MEDICAL
Bolton Surgical
Platts & Nisbett
Frankenman International
Changzhou Waston
Jiangsu Qianjing Medical
Changzhou Anker Medical
Changzhou Tongchuang Medical
United States Oncology Biosimilars Market: Product Segment Analysis
Type 1
Type 2
Type 3
United States Oncology Biosimilars Market: Application Segment Analysis
Application 1
Application 2
Application 3
Reasons for Buying this Report
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a six-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
United States Oncology Biosimilars Market Research Report Forecast 2017-2021
CHAPTER 1 ONCOLOGY BIOSIMILARS MARKET OVERVIEW
1.1 Product Overview and Scope of Oncology Biosimilars
1.2 Oncology Biosimilars Market Segmentation by Type
1.2.1 United States Production Market Share of Oncology Biosimilars by Type in 2015
1.2.1 Type
1.2.2 Type
1.2.3 Type
1.3 Oncology Biosimilars Market Segmentation by Application
1.3.1 Oncology Biosimilars Consumption Market Share by Application in 2015
1.3.2 Application
1.3.3 Application
1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Oncology Biosimilars (2011-2021)
CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON ONCOLOGY BIOSIMILARS INDUSTRY
2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend
CHAPTER 3 UNITED STATES ONCOLOGY BIOSIMILARS MARKET COMPETITION BY MANUFACTURERS
3.1 United States Oncology Biosimilars Production and Share by Manufacturers (2015 and 2016)
3.2 United States Oncology Biosimilars Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Oncology Biosimilars Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Oncology Biosimilars Manufacturing Base Distribution, Production Area and Product Type
3.5 Oncology Biosimilars Market Competitive Situation and Trends
3.5.1 Oncology Biosimilars Market Concentration Rate
3.5.2 Oncology Biosimilars Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
CHAPTER 4 UNITED STATES ONCOLOGY BIOSIMILARS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 United States Oncology Biosimilars Production and Market Share by Type (2012-2017)
4.2 United States Oncology Biosimilars Revenue and Market Share by Type (2012-2017)
4.3 United States Oncology Biosimilars Price by Type (2012-2017)
4.4 United States Oncology Biosimilars Production Growth by Type (2012-2017)
CHAPTER 5 UNITED STATES ONCOLOGY BIOSIMILARS MARKET ANALYSIS BY APPLICATION
5.1 United States Oncology Biosimilars Consumption and Market Share by Application (2012-2017)
5.2 United States Oncology Biosimilars Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
5.3.1 Potential Applications
5.3.2 Emerging Markets/Countries
CHAPTER 6 UNITED STATES ONCOLOGY BIOSIMILARS MANUFACTURERS ANALYSIS
6.1 Covidien llc (Medtronic)
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Product Type, Application and Specification
6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Business Overview
6.2 Johnson & Johnson MEDICAL
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Product Type, Application and Specification
6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Business Overview
6.3 Bolton Surgical
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Product Type, Application and Specification
6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Business Overview
6.4 Platts & Nisbett
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Product Type, Application and Specification
6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Business Overview
6.5 Frankenman International
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Product Type, Application and Specification
6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Business Overview
6.6 Changzhou Waston
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Product Type, Application and Specification
6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Business Overview
6.7 Jiangsu Qianjing Medical
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Product Type, Application and Specification
6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Business Overview
6.8 Changzhou Anker Medical
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Product Type, Application and Specification
6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Business Overview
6.9 Changzhou Tongchuang Medical
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Product Type, Application and Specification
6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Business Overview
CHAPTER 7 ONCOLOGY BIOSIMILARS MANUFACTURING COST ANALYSIS
7.1 Oncology Biosimilars Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Oncology Biosimilars
CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
8.1 Oncology Biosimilars Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Oncology Biosimilars Major Manufacturers in 2015
8.4 Downstream Buyers
CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
CHAPTER 11 UNITED STATES ONCOLOGY BIOSIMILARS MARKET FORECAST (2017-2021)
11.1 United States Oncology Biosimilars Production, Revenue Forecast (2017-2021)
11.2 United States Oncology Biosimilars Production, Consumption Forecast by Regions (2017-2021)
11.3 United States Oncology Biosimilars Production Forecast by Type (2017-2021)
11.4 United States Oncology Biosimilars Consumption Forecast by Application (2017-2021)
11.5 Oncology Biosimilars Price Forecast (2017-2021)
CHAPTER 12 APPENDIX
CHAPTER 1 ONCOLOGY BIOSIMILARS MARKET OVERVIEW
1.1 Product Overview and Scope of Oncology Biosimilars
1.2 Oncology Biosimilars Market Segmentation by Type
1.2.1 United States Production Market Share of Oncology Biosimilars by Type in 2015
1.2.1 Type
1.2.2 Type
1.2.3 Type
1.3 Oncology Biosimilars Market Segmentation by Application
1.3.1 Oncology Biosimilars Consumption Market Share by Application in 2015
1.3.2 Application
1.3.3 Application
1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Oncology Biosimilars (2011-2021)
CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON ONCOLOGY BIOSIMILARS INDUSTRY
2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend
CHAPTER 3 UNITED STATES ONCOLOGY BIOSIMILARS MARKET COMPETITION BY MANUFACTURERS
3.1 United States Oncology Biosimilars Production and Share by Manufacturers (2015 and 2016)
3.2 United States Oncology Biosimilars Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Oncology Biosimilars Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Oncology Biosimilars Manufacturing Base Distribution, Production Area and Product Type
3.5 Oncology Biosimilars Market Competitive Situation and Trends
3.5.1 Oncology Biosimilars Market Concentration Rate
3.5.2 Oncology Biosimilars Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
CHAPTER 4 UNITED STATES ONCOLOGY BIOSIMILARS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 United States Oncology Biosimilars Production and Market Share by Type (2012-2017)
4.2 United States Oncology Biosimilars Revenue and Market Share by Type (2012-2017)
4.3 United States Oncology Biosimilars Price by Type (2012-2017)
4.4 United States Oncology Biosimilars Production Growth by Type (2012-2017)
CHAPTER 5 UNITED STATES ONCOLOGY BIOSIMILARS MARKET ANALYSIS BY APPLICATION
5.1 United States Oncology Biosimilars Consumption and Market Share by Application (2012-2017)
5.2 United States Oncology Biosimilars Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
5.3.1 Potential Applications
5.3.2 Emerging Markets/Countries
CHAPTER 6 UNITED STATES ONCOLOGY BIOSIMILARS MANUFACTURERS ANALYSIS
6.1 Covidien llc (Medtronic)
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Product Type, Application and Specification
6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Business Overview
6.2 Johnson & Johnson MEDICAL
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Product Type, Application and Specification
6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Business Overview
6.3 Bolton Surgical
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Product Type, Application and Specification
6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Business Overview
6.4 Platts & Nisbett
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Product Type, Application and Specification
6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Business Overview
6.5 Frankenman International
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Product Type, Application and Specification
6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Business Overview
6.6 Changzhou Waston
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Product Type, Application and Specification
6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Business Overview
6.7 Jiangsu Qianjing Medical
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Product Type, Application and Specification
6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Business Overview
6.8 Changzhou Anker Medical
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Product Type, Application and Specification
6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Business Overview
6.9 Changzhou Tongchuang Medical
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Product Type, Application and Specification
6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Business Overview
CHAPTER 7 ONCOLOGY BIOSIMILARS MANUFACTURING COST ANALYSIS
7.1 Oncology Biosimilars Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Oncology Biosimilars
CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
8.1 Oncology Biosimilars Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Oncology Biosimilars Major Manufacturers in 2015
8.4 Downstream Buyers
CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
CHAPTER 11 UNITED STATES ONCOLOGY BIOSIMILARS MARKET FORECAST (2017-2021)
11.1 United States Oncology Biosimilars Production, Revenue Forecast (2017-2021)
11.2 United States Oncology Biosimilars Production, Consumption Forecast by Regions (2017-2021)
11.3 United States Oncology Biosimilars Production Forecast by Type (2017-2021)
11.4 United States Oncology Biosimilars Consumption Forecast by Application (2017-2021)
11.5 Oncology Biosimilars Price Forecast (2017-2021)
CHAPTER 12 APPENDIX
LIST OF TABLES AND FIGURES
Figure Picture of Oncology Biosimilars
Table Classification of Oncology Biosimilars
Figure United States Sales Market Share of Oncology Biosimilars by Type in 2015
Table Application of Oncology Biosimilars
Figure United States Sales Market Share of Oncology Biosimilars by Application in 2015
Figure United States Oncology Biosimilars Sales and Growth Rate (2011-2021)
Figure United States Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Table United States Oncology Biosimilars Sales of Key Manufacturers (2015 and 2016)
Table United States Oncology Biosimilars Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Oncology Biosimilars Sales Share by Manufacturers
Figure 2016 Oncology Biosimilars Sales Share by Manufacturers
Table United States Oncology Biosimilars Revenue by Manufacturers (2015 and 2016)
Table United States Oncology Biosimilars Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Oncology Biosimilars Revenue Share by Manufacturers
Table 2016 United States Oncology Biosimilars Revenue Share by Manufacturers
Table United States Market Oncology Biosimilars Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Oncology Biosimilars Average Price of Key Manufacturers in 2015
Figure Oncology Biosimilars Market Share of Top 3 Manufacturers
Figure Oncology Biosimilars Market Share of Top 5 Manufacturers
Table United States Oncology Biosimilars Sales by Type (2012-2017)
Table United States Oncology Biosimilars Sales Share by Type (2012-2017)
Figure United States Oncology Biosimilars Sales Market Share by Type in 2015
Table United States Oncology Biosimilars Revenue and Market Share by Type (2012-2017)
Table United States Oncology Biosimilars Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Oncology Biosimilars by Type (2012-2017)
Table United States Oncology Biosimilars Price by Type (2012-2017)
Figure United States Oncology Biosimilars Sales Growth Rate by Type (2012-2017)
Table United States Oncology Biosimilars Sales by Application (2012-2017)
Table United States Oncology Biosimilars Sales Market Share by Application (2012-2017)
Figure United States Oncology Biosimilars Sales Market Share by Application in 2015
Table United States Oncology Biosimilars Sales Growth Rate by Application (2012-2017)
Figure United States Oncology Biosimilars Sales Growth Rate by Application (2012-2017)
Table Covidien llc (Medtronic) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Covidien llc (Medtronic) Oncology Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Covidien llc (Medtronic) Oncology Biosimilars Market Share (2012-2017)
Table Johnson & Johnson MEDICAL Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Johnson & Johnson MEDICAL Oncology Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Johnson & Johnson MEDICAL Oncology Biosimilars Market Share (2012-2017)
Table Bolton Surgical Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bolton Surgical Oncology Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Bolton Surgical Oncology Biosimilars Market Share (2012-2017)
Table Platts & Nisbett Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Platts & Nisbett Oncology Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Platts & Nisbett Oncology Biosimilars Market Share (2012-2017)
Table Frankenman International Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Frankenman International Oncology Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Frankenman International Oncology Biosimilars Market Share (2012-2017)
Table Changzhou Waston Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Changzhou Waston Oncology Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Changzhou Waston Oncology Biosimilars Market Share (2012-2017)
Table Jiangsu Qianjing Medical Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Jiangsu Qianjing Medical Oncology Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Jiangsu Qianjing Medical Oncology Biosimilars Market Share (2012-2017)
Table Changzhou Anker Medical Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Changzhou Anker Medical Oncology Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Changzhou Anker Medical Oncology Biosimilars Market Share (2012-2017)
Table Changzhou Tongchuang Medical Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Changzhou Tongchuang Medical Oncology Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Changzhou Tongchuang Medical Oncology Biosimilars Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oncology Biosimilars
Figure Manufacturing Process Analysis of Oncology Biosimilars
Figure Oncology Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Oncology Biosimilars Major Manufacturers in 2015
Table Major Buyers of Oncology Biosimilars
Table Distributors/Traders List
Figure United States Oncology Biosimilars Production and Growth Rate Forecast (2017-2021)
Figure United States Oncology Biosimilars Revenue and Growth Rate Forecast (2017-2021)
Table United States Oncology Biosimilars Production Forecast by Type (2017-2021)
Table United States Oncology Biosimilars Consumption Forecast by Application (2017-2021)
COMPANIES MENTIONED
Covidien llc (Medtronic), Johnson & Johnson MEDICAL, Bolton Surgical, Platts & Nisbett, Frankenman International, Changzhou Waston, Jiangsu Qianjing Medical, Changzhou Anker Medical, Changzhou Tongchuang Medical, Jiangsu Reable Medical, Changzhou Resource Medical, Jiangsu Kangjin Medical, Pfizer, Wockhardt
Figure Picture of Oncology Biosimilars
Table Classification of Oncology Biosimilars
Figure United States Sales Market Share of Oncology Biosimilars by Type in 2015
Table Application of Oncology Biosimilars
Figure United States Sales Market Share of Oncology Biosimilars by Application in 2015
Figure United States Oncology Biosimilars Sales and Growth Rate (2011-2021)
Figure United States Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Table United States Oncology Biosimilars Sales of Key Manufacturers (2015 and 2016)
Table United States Oncology Biosimilars Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Oncology Biosimilars Sales Share by Manufacturers
Figure 2016 Oncology Biosimilars Sales Share by Manufacturers
Table United States Oncology Biosimilars Revenue by Manufacturers (2015 and 2016)
Table United States Oncology Biosimilars Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Oncology Biosimilars Revenue Share by Manufacturers
Table 2016 United States Oncology Biosimilars Revenue Share by Manufacturers
Table United States Market Oncology Biosimilars Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Oncology Biosimilars Average Price of Key Manufacturers in 2015
Figure Oncology Biosimilars Market Share of Top 3 Manufacturers
Figure Oncology Biosimilars Market Share of Top 5 Manufacturers
Table United States Oncology Biosimilars Sales by Type (2012-2017)
Table United States Oncology Biosimilars Sales Share by Type (2012-2017)
Figure United States Oncology Biosimilars Sales Market Share by Type in 2015
Table United States Oncology Biosimilars Revenue and Market Share by Type (2012-2017)
Table United States Oncology Biosimilars Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Oncology Biosimilars by Type (2012-2017)
Table United States Oncology Biosimilars Price by Type (2012-2017)
Figure United States Oncology Biosimilars Sales Growth Rate by Type (2012-2017)
Table United States Oncology Biosimilars Sales by Application (2012-2017)
Table United States Oncology Biosimilars Sales Market Share by Application (2012-2017)
Figure United States Oncology Biosimilars Sales Market Share by Application in 2015
Table United States Oncology Biosimilars Sales Growth Rate by Application (2012-2017)
Figure United States Oncology Biosimilars Sales Growth Rate by Application (2012-2017)
Table Covidien llc (Medtronic) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Covidien llc (Medtronic) Oncology Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Covidien llc (Medtronic) Oncology Biosimilars Market Share (2012-2017)
Table Johnson & Johnson MEDICAL Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Johnson & Johnson MEDICAL Oncology Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Johnson & Johnson MEDICAL Oncology Biosimilars Market Share (2012-2017)
Table Bolton Surgical Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bolton Surgical Oncology Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Bolton Surgical Oncology Biosimilars Market Share (2012-2017)
Table Platts & Nisbett Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Platts & Nisbett Oncology Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Platts & Nisbett Oncology Biosimilars Market Share (2012-2017)
Table Frankenman International Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Frankenman International Oncology Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Frankenman International Oncology Biosimilars Market Share (2012-2017)
Table Changzhou Waston Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Changzhou Waston Oncology Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Changzhou Waston Oncology Biosimilars Market Share (2012-2017)
Table Jiangsu Qianjing Medical Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Jiangsu Qianjing Medical Oncology Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Jiangsu Qianjing Medical Oncology Biosimilars Market Share (2012-2017)
Table Changzhou Anker Medical Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Changzhou Anker Medical Oncology Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Changzhou Anker Medical Oncology Biosimilars Market Share (2012-2017)
Table Changzhou Tongchuang Medical Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Changzhou Tongchuang Medical Oncology Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Changzhou Tongchuang Medical Oncology Biosimilars Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oncology Biosimilars
Figure Manufacturing Process Analysis of Oncology Biosimilars
Figure Oncology Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Oncology Biosimilars Major Manufacturers in 2015
Table Major Buyers of Oncology Biosimilars
Table Distributors/Traders List
Figure United States Oncology Biosimilars Production and Growth Rate Forecast (2017-2021)
Figure United States Oncology Biosimilars Revenue and Growth Rate Forecast (2017-2021)
Table United States Oncology Biosimilars Production Forecast by Type (2017-2021)
Table United States Oncology Biosimilars Consumption Forecast by Application (2017-2021)
COMPANIES MENTIONED
Covidien llc (Medtronic), Johnson & Johnson MEDICAL, Bolton Surgical, Platts & Nisbett, Frankenman International, Changzhou Waston, Jiangsu Qianjing Medical, Changzhou Anker Medical, Changzhou Tongchuang Medical, Jiangsu Reable Medical, Changzhou Resource Medical, Jiangsu Kangjin Medical, Pfizer, Wockhardt
